J&J's Stoffels, who managed development of the company's COVID-19 shot, is retiring
Published
Oct 12 2021 at 2:16 PM GMT
Key
Points
Points
- Dr Paul Stoffels, the executive running Johnson & Johnson's COVID-19 vaccine program, announced he will retire at the end of the year, the company said Tuesday.
- As J&J's chief scientific officer and vice chair of the executive committee, Stoffels is in charge of the company's research and product pipeline.
- He previously ran J&J's pharmaceuticals business.
- J&J CEO Alex Gorsky announced in August that he is stepping down at the end of 2021.
- J&J's stock is down 1 0% for the year, while the broader S&P 500 has gained 16.
Trending
Stats
- Published Oct 12, 2021 2:16 PM GMT